Procter & Gamble (NYSE:PG) Given Outperform Rating at Royal Bank Of Canada

Procter & Gamble (NYSE:PG)‘s stock had its “outperform” rating restated by analysts at Royal Bank Of Canada in a note issued to investors on Tuesday, Benzinga reports. They currently have a $166.00 price target on the stock. Royal Bank Of Canada’s target price would suggest a potential upside of 4.93% from the stock’s current price.

PG has been the topic of a number of other research reports. Jefferies Financial Group upped their target price on shares of Procter & Gamble from $177.00 to $179.00 and gave the company a “buy” rating in a research note on Friday, June 26th. UBS Group restated a “buy” rating on shares of Procter & Gamble in a research note on Friday. Argus lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Friday, August 7th. HSBC restated a “hold” rating and issued a $149.00 target price (down from $182.00) on shares of Procter & Gamble in a research note on Thursday, July 30th. Finally, JPMorgan Chase & Co. cut their target price on shares of Procter & Gamble from $164.00 to $162.00 and set an “overweight” rating on the stock in a research note on Thursday, July 16th. Fourteen investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $162.20.

Procter & Gamble Trading Up 0.3%

Shares of NYSE PG traded up $0.51 during trading on Tuesday, hitting $158.20. 517,860 shares of the company traded hands, compared to its average volume of 9,654,931. Procter & Gamble has a 1 year low of $137.62 and a 1 year high of $167.25. The company has a 50-day moving average price of $147.11 and a 200-day moving average price of $146.62. The firm has a market capitalization of $367.45 billion, a P/E ratio of 23.95, a P/E/G ratio of 3.96 and a beta of 0.39. The company has a quick ratio of 0.47, a current ratio of 0.68 and a debt-to-equity ratio of 0.43.

Procter & Gamble (NYSE:PG) last posted its earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.02. The business had revenue of $21.20 billion for the quarter, compared to analyst estimates of $21.38 billion. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The business’s quarterly revenue was up 1.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, equities analysts predict that Procter & Gamble will post 6.98 EPS for the current year.

Insiders Place Their Bets

In other news, CAO Matthew Janzaruk sold 359 shares of the stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $145.24, for a total value of $52,141.16. Following the completion of the transaction, the chief accounting officer directly owned 1,271 shares in the company, valued at $184,600.04. This trade represents a 22.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Susan Whaley sold 2,369 shares of the stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $145.34, for a total transaction of $344,310.46. Following the completion of the transaction, the insider owned 30,730 shares of the company’s stock, valued at $4,466,298.20. This trade represents a 7.16% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 15,135 shares of company stock valued at $2,189,970. 0.23% of the stock is currently owned by insiders.

Institutional Trading of Procter & Gamble

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Net Worth Advisory Group raised its holdings in shares of Procter & Gamble by 13.2% in the third quarter. Net Worth Advisory Group now owns 6,019 shares of the company’s stock valued at $866,000 after purchasing an additional 702 shares during the last quarter. Boyd Wealth Management LLC boosted its holdings in shares of Procter & Gamble by 12.7% in the 3rd quarter. Boyd Wealth Management LLC now owns 4,146 shares of the company’s stock worth $602,000 after buying an additional 468 shares during the last quarter. Lakeside Advisors INC. boosted its holdings in shares of Procter & Gamble by 2.4% in the 3rd quarter. Lakeside Advisors INC. now owns 38,587 shares of the company’s stock worth $5,606,000 after buying an additional 905 shares during the last quarter. Focused Alpha LLC purchased a new position in shares of Procter & Gamble in the 3rd quarter worth about $224,000. Finally, Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in Procter & Gamble by 1.4% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 593,845 shares of the company’s stock worth $86,274,000 after purchasing an additional 8,378 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Dividend reliability remains a major attraction. Procter & Gamble is highlighted as a “Dividend King” with roughly seven decades of consecutive payout increases. Its income consistency and relatively low-beta business model may appeal to investors seeking stability amid interest-rate and market volatility. Rising Income Over Big Yields: 4 Dividend Kings That Have Raised Payouts for 70 Years Straight
• Positive Sentiment: Innovation efforts could revive organic sales growth. New products, AI-enabled capabilities, productivity initiatives and efforts to strengthen brand market share are being viewed as potential longer-term catalysts. Procter & Gamble’s Innovation Push: Catalyst for Long-Term Growth?
• Positive Sentiment: Head & Shoulders is receiving a targeted product refresh. The new Scalp Care Collection uses clinically tested formulas aimed at dryness, oiliness and sensitivity, potentially improving brand relevance and supporting premium, science-led growth. Why Is Procter & Gamble Refreshing Its Scalp Care Playbook Now?
• Neutral Sentiment: Fiscal first-quarter results are the immediate catalyst. Analysts expect PG to report before the market opens on October 22, with attention on organic sales, volumes, pricing, margins and management’s outlook. The company’s prior quarter showed modest revenue growth and an EPS beat, but revenue fell short of estimates. Procter & Gamble Reports Q1 Earnings on October 22
• Negative Sentiment: Pricing remains a key risk. The earnings preview frames the central tension as a possible recovery in sales volumes versus pricing headwinds. If consumers resist higher prices or volumes remain weak, revenue and organic-growth expectations could come under pressure. Procter & Gamble Earnings Preview: Volume Recovery vs. Pricing Headwind

Procter & Gamble Company Profile

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.